Tumor necrosis factor-α-induced accentuation in cryoinjury: Mechanisms in vitro and in vivo

Molecular Cancer Therapeutics

Volumn 7, Issue 8, 2008, Pages 2547-2555

  Jiang, Jing ^a   Goel, Raghav ^a   Iftekhar, M Arif ^a   Visaria, Rachana ^a   Belcher, John D ^a   Vercellotti, Gregory M ^a   Bischof, John C ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; COLD INJURY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MICROVASCULATURE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SKIN;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CRYOSURGERY; HUMANS; MALE; MICE; NF-KAPPA B; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53349118231     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-2421     Document Type: Article

References (47)

1. Pease GR, Wong ST, Roos MS, Rubinsky B. MR image-guided control of cryosurgery. J Magn Reson Imaging 1995;5:753-60.
2. Rubinsky B. Cryosurgery. Annu Rev Biomed Eng 2000;2:157-87.
3. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN, Jr. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001;57: 518-23.
4. Ikekawa S, Ishihara K, Tanaka S, Ikeda S. Basic studies of cryochemotherapy in a murine tumor system. Cryobiology 1985;22:477-83.
5. Chao BH, He X, Bischof JC. Pre-treatment inflammation induced by TNF-α augments cryosurgical injury on human prostate cancer. Cryobiology 2004;49:10-27.
6. Mir LM, Rubinsky B. Treatment of cancer with cryochemotherapy. Br J Cancer 2002;86:1658-60.
7. Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology 2001;42:274-85.
8. Goel R, Swanlund D, Coad J, Paciotti GF, Bischof JC. TNF-α-based accentuation in cryoinjury-dose, delivery, and response. Mol Cancer Ther 2007;6:2039-47.
9. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998;37:171-86.
10. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002;60:40-9.
11. Mazur P. The role of cell membranes in the freezing of yeast and other single cells. Ann N Y Acad Sci 1965;125:658-76.
12. Rabb JM, Renaud ML, Brandt PA, Witt CW. Effect of freezing and thawing on the microcirculation and capillary endothelium of the hamster cheek pouch. Cryobiology 1974;11:508-18.
13. Marzella L, Jesudass RR, Manson PN, Myers RA, Bulkley GB. Morphologic characterization of acute injury to vascular endothelium of skin after frostbite. Plast Reconstr Surg 1989;83:67-76.
14. Hoffmann NE, Bischof, JB. Mechanisms of injury caused by in vivo freezing. In: Benson E, Fuller B, Lane N, editors. Life in frozen state. Taylor & Francis; 2003. p. 437-81.
15. Eberl T, Amberger A, Herold M, et al. Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation. Cryobiology 1999;38:106-18.
16. Forest V, Peoc'h M, Campos L, Guyotat D, Vergnon JM. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology 2005;50:29-37.
17. Tatsutani KN, Joye JD, Virmani R, Taylor MJ. In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing. Cryo Letters 2005;26:55-64.
18. Mocellin S, Rossi CR, Pilati P, Nitti D. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 2005;16:35-53.
19. Szlosarek PW, Balkwill FR. Tumour necrosis factor a: a potential target for the therapyof solid tumours. Lancet Oncol 2003;4:565-73.
20. Watanabe N, Niitsu Y, Umeno H, et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res 1988;48:2179-83.
21. van Horssen R, Ten Hagen TL, Eggermont AM. TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006;11:397-408.
22. Gupta K, Ramakrishnan S, Browne PV, et al. A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation of panning and stimulation with vascular endothelial growth factor. Exp Cell Res 1997;230:244-51.
23. Park H, Lyons JC, Griffin RJ, Lim BU, Song CW. Apoptosis and cell cycle progression in an acidic environment after irradiation. Radiat Res 2000;153:295-304.
24. Hoffmann NE, Bischof JC. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber. Part I. Thermal response. J Biomech Eng 2001;123:301-9.
25. Papenfuss HD, Gross JF, Intaglietta M, Treese FA. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979;18:311-8.
26. Hoffmann NE, Bischof JC. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber. Part II. Injuryresponse. J Biomech Eng 2001;123:310-6.
27. Pierce JW, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997;272:21096-103.
28. Mabuchi S, Ohmichi M, Nishio Y, et al. Inhibition of inhibitor of nuclear factor-κB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res 2004;10:7645-54.
29. Xia YF, Ye BQ, Li YD, et al. Andrographolide attenuates inflammation byinhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50. J Immunol 2004;173:4207-17.
30. Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK. Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 1995;55:4824-9.
31. Pfeil K, Eder IE, Putz T, et al. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Prostate 2004;58:259-68.
32. Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998;187:587-600.
33. Lucas R, Garcia I, Donati YR, et al. Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol 1998;28:3577-86.
34. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000;96:2451-9.
35. Berrada MS, Bischof JC. Evaluation of freezing effects on human microvascular-endothelial cells (HMEC). Cryo Letters 2001;22:353-66.
36. Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch 2005;446:475-82.
37. Nawroth P, Handley D, Matsueda G, et al. Tumor necrosis factor/ cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 1988;168:637-47.
38. Renard N, Lienard D, Lespagnard L, Eggermont A, Heimann R, Lejeune F. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor a (rTNFα). Int J Cancer 1994;57:656-63.
39. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-90.
40. Greten FR, Karin M. The IKK/NF-κB activation pathway - a target for prevention and treatment of cancer. Cancer Lett 2004;206:193-9.
41. Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 2005;115:2625-32.
42. Mabuchi S, Ohmichi M, Nishio Y, et al. Inhibition of NFκB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 2004;279:23477-85.
43. Huerta-Yepez S, Vega M, Jazirehi A, et al. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xl expression. Oncogene 2004;23:4993-5003.
44. Rokhlin OW, Gudkov AV, Kwek S, Glover RA, Gewies AS, Cohen MB. p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene 2000;19:1959-68.
45. Granville DJ, Shaw JR, Leong S, et al. Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am J Pathol 1999;155:1021-5.
46. Forest V, Peoc'h M, Ardiet C, Campos L, Guyotat D, Vergnon JM. In vivo cryochemotherapy of a human lung cancer model. Cryobiology 2005;51:92-101.
47. Steinbach JP, Weissenberger J, Aguzzi A. Distinct phases of cryogenic tissue damage in the cerebral cortex of wild-type and c-fos deficient mice. Neuropathol Appl Neurobiol 1999;25:468-80.